Lebwohl, M.; Kircik, L. .; Moore, A.; Stein Gold, L.; Del Rosso, J.; Draelos, Z.; Gooderham, M.; Green, L.; Herbert, A.; Papp, K.; Bagel, J. .; Bhatia, N.; Ferris, L.; Jones, T. .; Kempers, S.; Pariser, D.; Yamauchi, P.; Zirwas, M.; Feng, A. .; Burnett, P.; Higham, R.; Berk, D. Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials. J of Skin 2021, 5, s42.